Stefan Stremitzer
Overview
Explore the profile of Stefan Stremitzer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
406
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kampf S, Sponder M, Fitschek F, Laxar D, Bodingbauer M, Binder C, et al.
Hepatobiliary Surg Nutr
. 2023 Oct;
12(5):704-714.
PMID: 37886202
Background: Obesity and associated steatosis is an increasing health problem worldwide. Its influence on post-hepatectomy liver failure (PHLF) and after liver resection (LR) is still unclear. Methods: Patients who underwent...
2.
Schwarz C, Schmidbauer V, Lagler H, Stremitzer S, Kaczirek K, Langenberger H, et al.
J Travel Med
. 2023 Aug;
30(6).
PMID: 37565821
No abstract available.
3.
Hotz J, Kaczirek K, Stremitzer S, Waneck F, Auer H, Perkmann T, et al.
Pathogens
. 2022 Feb;
11(2).
PMID: 35215203
Echinococcosis is a neglected zoonotic disease and a worldwide public health problem caused by infection with the larval stages of taeniid cestodes of the genus . In vitro studies have...
4.
Stift J, Graf A, Neudert B, Herac M, Woeran K, Tamandl D, et al.
HPB (Oxford)
. 2021 Jun;
24(1):40-46.
PMID: 34158230
Background: The clinical value of immune checkpoint expression as prognostic biomarker in bevacizumab-pretreated patients with resected microsatellite-stable (MMS) colorectal liver metastases is unclear and was retrospectively investigated in this study....
5.
Stremitzer S, Stift J, Laengle J, Schwarz C, Kaczirek K, Jones R, et al.
Ann Surg Oncol
. 2020 Sep;
28(3):1493-1498.
PMID: 32914390
Background: Resection margin status is a known prognosticator in patients who undergo resection for hilar cholangiocarcinoma. However, the influence of an isolated positive circumferential margin on clinical outcome is unclear....
6.
Stremitzer S, Vermeulen P, Graver S, Kockx M, Dirix L, Yang D, et al.
Br J Cancer
. 2020 Mar;
122(10):1518-1524.
PMID: 32205863
Background: Patients with desmoplastic (angiogenic) histopathological growth pattern (HGP) colorectal liver metastases (CLM) might derive more benefit from bevacizumab-based chemotherapy than those with replacement (non-angiogenic) HGP. This study investigated the...
7.
Schwarz C, Plass I, Fitschek F, Punzengruber A, Mittlbock M, Kampf S, et al.
Sci Rep
. 2019 Jun;
9(1):8421.
PMID: 31182746
Postoperative liver dysfunction remains a major concern following hepatic resection. In order to identify patients who are at risk of developing liver dysfunction, indocyanine green (ICG) clearance has been proposed...
8.
Stremitzer S, Jones R, Quinn L, Fenwick S, Diaz-Nieto R, Poston G, et al.
Eur J Surg Oncol
. 2018 Oct;
45(2):213-217.
PMID: 30360988
Background: Liver transplantation in patients with unresectable early-stage (<3 cm, node negative) hilar cholangiocarcinoma has been recently reported to be associated with longer survival compared to liver resection and therefore...
9.
Bhangu J, Beer A, Mittlbock M, Tamandl D, Pulverer W, Schonthaler S, et al.
Ann Surg
. 2018 Aug;
268(5):894-902.
PMID: 30080722
Background: Neoadjuvant chemotherapy (neoCTx) followed by hepatic resection is the treatment of choice for patients with colorectal cancer liver metastasis (CLM). Treatment response is generally assessed using radiologic imaging after...
10.
Laengle J, Stift J, Bilecz A, Wolf B, Beer A, Hegedus B, et al.
Theranostics
. 2018 Jun;
8(12):3198-3213.
PMID: 29930723
Preclinical models indicate that DNA damage induces type I interferon (IFN), which is crucial for the induction of an anti-tumor immune response. In human cancers, however, the association between DNA...